Pacira BioSciences, Inc. (PCRX) free cash flow

Free cash flow · fiscal 2025
$136.66M

Pacira BioSciences, Inc. (PCRX) generated free cash flow of $136.66M in fiscal 2025 (the year ended December 31, 2025). That is 23.5% lower than the $178.75M of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$136.66M
Change on fiscal 2024
−23.5%
Growth, 5 years
+28.4% a year
Highest on record
$178.75Mfiscal 2024
Lowest on record
-$88.39Mfiscal 2012
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pacira BioSciences, Inc. free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 28.4% a year. Across the 17 fiscal years on record (2009–2025), the highest was $178.75M in fiscal 2024 and the lowest -$88.39M in fiscal 2012.

History · 17 fiscal years

Free cash flow by fiscal year

Pacira BioSciences, Inc. free cash flow, year by year

Pacira BioSciences, Inc. (PCRX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$136.66M 23.5% down
2024$178.75M 28.1% up
2023$139.49M 21.1% up
2022$115.20M 44.3% up
2021$79.85M 103.5% up
2020$39.23M 35.0% down
2019$60.36M 75.7% up
2018$34.36M—
2017-$1.48M 116.9% down
2016$8.74M—
2015-$12.27M 442.8% down
2014$3.58M—
2013-$56.01M—
2012-$88.39M—
2011-$37.17M—
2010-$31.65M—
2009-$26.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on PCRX

Pacira BioSciences, Inc., figure by figure

Pacira BioSciences, Inc. (PCRX) overview: price, valuation and scorecard

Pacira BioSciences, Inc. free cash flow: questions and answers

What is Pacira BioSciences, Inc.'s free cash flow?

Pacira BioSciences, Inc. (PCRX) generated free cash flow of $136.66M in fiscal 2025 (the year ended December 31, 2025). That is 23.5% lower than the $178.75M of fiscal 2024.

What is the growth rate of Pacira BioSciences, Inc.'s free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 28.4% a year.

What are the highest and lowest free cash flow figures on record for Pacira BioSciences, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $178.75M in fiscal 2024 and the lowest -$88.39M in fiscal 2012.

How is Pacira BioSciences, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Pacira BioSciences, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pacira BioSciences, Inc. (PCRX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/PCRX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.